Replies to post #231671 on Cytodyn Inc (CYDY)

[justdafactss]

Speaking of results, where exactly can the 82% nonsense youve been yodeling for years be found on the clinical trials.gov website?

Please point that out with link included.

I found the Principal Investigator list so why didnt CYDY want to divulge a designated PI on the main Study page?---

Contacts/Locations
Central Contact Person
Name
Kush Dhody, MBBS, MS, CCRA
Telephone
301-956-2536
Email
[e-mail]
Study Officials

Location
Alexander City, Alabama, United States, 35010
Status:
Recruiting
Facility:
Advanced Cardiovascular, LLC
Contact:
Contact
Sabrina Forbus, RN, BSN
256-215-5323
Principal Investigator
William Ross Davis, MD
Fullerton, California, United States, 92835
Status:
Recruiting
Facility:
St. Jude Medical Center
Contact:
Contact
Blanca Sanchez
714-446-5620
[e-mail]
Principal Investigator
David J Park, MD
Los Angeles, California, United States, 90095
Status:
Recruiting
Facility:
UCLA
Contact:
Contact
Nancy Lopez
310-794-8043
[e-mail]
Principal Investigator
Otto Yang, MD
Tampa, Florida, United States, 33612
Status:
Recruiting
Facility:
James A. Haley Veterans' Hospital
Contact:
Contact
Adam Zoble
813-631-3671
[e-mail]
Principal Investigator
Koushik Reddy, MD
Gainesville, Georgia, United States, 30501
Status:
Active, not recruiting
Facility:
Center for Advanced Research & Education (CARE)
Boston, Massachusetts, United States, 02215
Status:
Recruiting
Facility:
Beth Israel Deaconess Medical Center
Contact:
Contact
Caitlin Davis
617-735-4466
[e-mail]
Principal Investigator
Sabrina Tan, MD
Livingston, New Jersey, United States, 07052
Status:
Recruiting
Facility:
St. Barnabas
Contact:
Principal Investigator
Subroto Paul, MD
Morristown, New Jersey, United States, 07962-1905
Status:
Recruiting
Facility:
Atlantic Health System Hospital
Contact:
Principal Investigator
Eric Whitman, MD
Teaneck, New Jersey, United States, 07666
Status:
Recruiting
Facility:
Holy Name Medical Center
Contact:
Contact
Patty Kiledjian
201-541-6312
[e-mail]
Principal Investigator
Benjamin De La Rosa, MD
Bronx, New York, United States, 10467
Status:
Recruiting
Facility:
Montefiore Medical Center
Contact:
Contact
Jane Wilson
718-920-7916
Principal Investigator
Harish Seethamraju, MD
Brooklyn, New York, United States, 11229
Status:
Recruiting
Facility:
New York Community Hospital of Brooklyn
Contact:
Contact
Marina Bilik
718-692-5336
[e-mail]
Principal Investigator
Isaia Avraham, MD
Winston-Salem, North Carolina, United States, 27103
Status:
Recruiting
Facility:
Novant Health
Contact:
Contact
Shannon Bowman
[e-mail]
Contact
Pailing Richards
704-996-7627
[e-mail]
Principal Investigator
Michael Morgan, MD
Columbus, Ohio, United States, 43215
Status:
Recruiting
Facility:
Ohio Health
Contact:
Principal Investigator
Kiran Devulapally, MD
Corvallis, Oregon, United States, 97330
Status:
Recruiting
Facility:
Good Samaritan Hospital Corvallis
Contact:
Contact
Stephanie Mock
541-768-4352
[e-mail]
Principal Investigator
Brian Delmonaco, MD
Portland, Oregon, United States, 97239
Status:
Recruiting
Facility:
Oregon Health and Sciences University
Contact:
Principal Investigator
Marcel Curlin, MD
Dallas, Texas, United States, 75204
Status:
Recruiting
Facility:
Baylor Scott & White Research Institute
Contact:
Contact
Samantha Wang
[e-mail]
Principal Investigator
Uriel Sandkovsky
Houston, Texas, United States, 77030
Status:
Recruiting
Facility:
Baylor College of Medicine
Contact:
Contact
Hinali Zaveri, MD
713-873-2353
[e-mail]
Principal Investigator
Kalpalatha Guntupalli, MD
Houston, Texas, United States, 77030
Status:
Recruiting
Facility:
University of Texas
Contact:
Contact
Jordan Lake
713-500-6767
[e-mail]
Principal Investigator
Jordan Lake, MD
https://www.clinicaltrials.gov/study/NCT04347239?intr=leronlimab&rank=8&tab=history&a=13#contacts-locations-card

[$5.95akadawson-m]

I'm going to do a little math tonight. I doubt the four idiots on this board will be able to follow even though they can read...

These numbers apply to a different stock and company but what I am presenting will cleave Grip's "boys" from his undies because the Gripper has pounded the table that by June, CYDY's stock price will be ten cents. I'll go even further and state that CYDY is not going bankrupt for a couple of good reasons tied to the numbers from a different company. Check it out. I copied these numbers from a poster on another board. The closing price of this company today is about $5.80 a share.

I think $9 is reasonable based on my modeling. Here is what I have for NonGAAP '24:
$1,757.8 Revenue
$733.9 Gross Margin
$351.6 Research and Development
$165.2 Sales and Marketing
$104.6 General and Administrative
$621.4 OPEX
$112.5 Operating Income
$13.5 Tax
$99.0 Net Income
R&D is higher YoY due to spending on hyperscale
G&A is slightly lower YoY due to lower fees from EY (restatement issue behind them)
Total EPS is 0.37 cents which is about a 28% increase YoY (Not sure what Q4 '23 EPS is quite yet). Assuming no irrational exuberance on the stock price, this derives a $9.13 price target. If the street goes a little nuts and gets ahead of its skis a little bit, it is possible we can see $11 by the end of the year.

The company is Infinera and do you know who the Founder and CTO is???? What he has in common with CYDY?

David Welch. Welch owns close to 50 MILLION shares of CYDY. Based on INFN's trajectory and stature in the field of optical networks, Welch is not
going to allow CYDY to fail. Have you seen that he owns two other biotechs? Get a grip, Grip. You're an idiot for stating your hubris.